Education
About Us
Working with TipRanks
Follow Us
DBV Technologies S.A. - American Depositary Shares (DBVT)
:DBVT
DBVT Stock Chart & Stats
$18.29
$0.34(9.80%)
At close: 4:00 PM EST
$18.29
$0.34(9.80%)
Day’s Range― - ―
52-Week Range$2.74 - $21.50
Previous CloseN/A
Volume52.91K
Average Volume (3M)329.10K
Market Cap
$759.45M
Enterprise Value$179.04M
Total Cash (Recent Filing)$69.84M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.06
Next Earnings
Mar 05, 2026EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding40,155,544
10 Day Avg. Volume717,156
30 Day Avg. Volume329,096
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.17
Price to Sales (P/S)0.00
P/FCF Ratio-0.56
Enterprise Value/Market Cap0.24
Enterprise Value/Revenue350.36
Enterprise Value/Gross Profit-13.91
Enterprise Value/Ebitda-1.54
Forecast
1Y Price Target
$30.40Price Target Upside66.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-2.09
Revenue Forecast (FY)$5.98M
Bulls Say, Bears Say
Bulls Say
Clinical TrialsVITESSE is the last major clinical risk for Viaskin, which has been largely de-risked due to changes in the clinical trial, such as narrowing the age band, larger N, and adjusted responder threshold, which increases the probability of success.
Market PotentialThe market opportunity for Viaskin Peanut is sizable, with caregivers highly motivated to treat and current options being burdensome.
Regulatory PathwaysA positive VITESSE readout could unlock both regulatory momentum and warrant-linked capital, extending runway into commercialization.
Bears Say
DBV Technologies SA - American News
DBVT FAQ
What was DBV Technologies S.A. - American Depositary Shares’s price range in the past 12 months?
DBV Technologies S.A. - American Depositary Shares lowest stock price was $2.74 and its highest was $21.50 in the past 12 months.
What is DBV Technologies S.A. - American Depositary Shares’s market cap?
DBV Technologies S.A. - American Depositary Shares’s market cap is $759.45M.
When is DBV Technologies S.A. - American Depositary Shares’s upcoming earnings report date?
DBV Technologies S.A. - American Depositary Shares’s upcoming earnings report date is Mar 05, 2026 which is in 79 days.
How were DBV Technologies S.A. - American Depositary Shares’s earnings last quarter?
DBV Technologies S.A. - American Depositary Shares released its earnings results on Oct 28, 2025. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.318 by $0.078.
Is DBV Technologies S.A. - American Depositary Shares overvalued?
According to Wall Street analysts DBV Technologies S.A. - American Depositary Shares’s price is currently Undervalued.
Does DBV Technologies S.A. - American Depositary Shares pay dividends?
DBV Technologies S.A. - American Depositary Shares does not currently pay dividends.
What is DBV Technologies S.A. - American Depositary Shares’s EPS estimate?
DBV Technologies S.A. - American Depositary Shares’s EPS estimate is -0.23.
How many shares outstanding does DBV Technologies S.A. - American Depositary Shares have?
DBV Technologies S.A. - American Depositary Shares has 40,155,544 shares outstanding.
What happened to DBV Technologies S.A. - American Depositary Shares’s price movement after its last earnings report?
DBV Technologies S.A. - American Depositary Shares reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.318. Following the earnings report the stock price went down -2.186%.
Which hedge fund is a major shareholder of DBV Technologies S.A. - American Depositary Shares?
Currently, no hedge funds are holding shares in DBVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DBV Technologies SA - American Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.40 (66.21% Upside)
$30.40 (66.21% Upside)
Blogger Sentiment
Bearish
DBVT Sentiment 70%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $23.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
412.32%
12-Months-Change
Fundamentals
Return on Equity
-234.58%
Trailing 12-Months
Asset Growth
18.74%
Trailing 12-Months
Company Description
DBV Technologies S.A. - American Depositary Shares
DBV Technologies SA is a biopharmaceutical company focused on developing and commercializing innovative therapies for food allergies and immunological diseases. The company is primarily engaged in the research and development of its proprietary Viaskin technology, which aims to provide a safe and effective method for desensitizing patients to allergens through epicutaneous immunotherapy. DBV Technologies operates in the biotechnology sector, with a core emphasis on addressing unmet medical needs in allergy treatment.
DBVT Stock 12 Month Forecast
Average Price Target
$30.40
▲(66.21% Upside)
Technical Analysis
Larimar Therapeutics
―
Korro Bio
―
4D Molecular Therapeutics
―
PureTech Health
―
Lexeo Therapeutics, Inc.
―